IDEAYA Biosciences, Inc. (IDYA) Free cash flow 2017–2025
IDEAYA Biosciences, Inc. (IDYA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$73.5MFY2025 · since FY2017: -$14.0M → -$73.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$73.5M | +70.8% |
| FY2024 | -$251.4M | -113.8% |
| FY2023 | -$117.6M | -29.8% |
| FY2022 | -$90.6M | -55.1% |
| FY2021 | -$58.4M | -206.3% |
| FY2020 | $55.0M | +235.2% |
| FY2019 | -$40.7M | -38.7% |
| FY2018 | -$29.3M | -109.8% |
| FY2017 | -$14.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating marginIDYA Operating cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →